Literature DB >> 12916772

Vitamin K requirement in Danish anticoagulant-resistant Norway rats (Rattus norvegicus).

Mette D K Markussen1, Ann-Charlotte Heiberg, Robert Nielsen, Herwig Leirs.   

Abstract

Resistance to warfarin has been connected to an increase in dietary requirement for vitamin K in British strains of the Norway rat, Rattus norvegicus (Berk). This study examines vitamin K requirement of Danish anticoagulant-resistant Norway rats using a vitamin K deficient feeding test. Wild bromadiolone-resistant rats sampled from different localities in Denmark and rats from bromadiolone-resistant and susceptible laboratory strains were fed on a vitamin K deficient diet over a maximum period of 15 days. Development of vitamin K deficiency, measured as reduced blood-clotting capacity, took place in 43% of the Danish resistant rats and was independent of sex, treatment with supplementary vitamin K3 and sampling locality. Development of deficiency was slower for resistant rats that were supplemented with vitamin K3 prior to the feeding test, suggesting storage of the vitamin K in a vitamin body pool. Intraperitoneal administration of vitamin K1 revealed that 80 microg vitamin K1 kg(-1) bodyweight was sufficient to restore normal blood clotting activity in deficient rats, while 60 microg vitamin K1 kg(-1) bodyweight was insufficient. We conclude that vitamin K requirement is moderately increased in Danish homozygous resistant rats whereas heterozygous resistant rats only have a minor increase in vitamin K requirement compared with susceptible rats. We found no indication of different resistance types being present in our test material since vitamin K requirement was not different between rats from separate sampling localities.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12916772     DOI: 10.1002/ps.703

Source DB:  PubMed          Journal:  Pest Manag Sci        ISSN: 1526-498X            Impact factor:   4.845


  4 in total

1.  Analysis of vkorc1 polymorphisms in Norway rats using the roof rat as outgroup.

Authors:  Juan C Díaz; Ying Song; Anthony Moore; Jeff N Borchert; Michael H Kohn
Journal:  BMC Genet       Date:  2010-05-24       Impact factor: 2.797

2.  A cardiovascular phenotype in warfarin-resistant Vkorc1 mutant rats.

Authors:  Michael H Kohn; Roger E Price; Hans-Joachim Pelz
Journal:  Artery Res       Date:  2008-11       Impact factor: 0.597

3.  The potential of VKORC1 polymorphisms in Mustelidae for evolving anticoagulant resistance through selection along the food chain.

Authors:  Matthias Stöck; Florian Reisch; Morten Elmeros; Doreen Gabriel; Werner Kloas; Eva Kreuz; Pia Lassen; Alexandra Esther
Journal:  PLoS One       Date:  2019-08-29       Impact factor: 3.240

4.  New insights into the catalytic mechanism of vitamin K epoxide reductase (VKORC1) - The catalytic properties of the major mutations of rVKORC1 explain the biological cost associated to mutations.

Authors:  Benjamin Matagrin; Ahmed Hodroge; Adrien Montagut-Romans; Julie Andru; Isabelle Fourel; Stéphane Besse; Etienne Benoit; Virginie Lattard
Journal:  FEBS Open Bio       Date:  2013-02-16       Impact factor: 2.693

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.